You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: 11,576,878


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,576,878 protect, and when does it expire?

Patent 11,576,878 protects ARYNTA and is included in one NDA.

This patent has seventeen patent family members in sixteen countries.

Summary for Patent: 11,576,878
Title:Oral solutions comprising lisdexamfetamine salts
Abstract:Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
Inventor(s):Georgios LIOLIOS, Ioannis Psarrakis
Assignee: Adalvo Ltd
Application Number:US16/961,784
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analysis of US Patent 11,576,878: Scope, Claims, and Patent Landscape

Introduction

United States Patent 11,576,878 (hereafter "the '878 patent") pertains to innovative developments within the pharmaceutical domain. As with every patent, understanding its scope, claims, and overall patent landscape is essential for stakeholders—be it pharmaceutical companies, investors, or legal professionals—to navigate potential IP risks and opportunities. This analysis dissects the patent’s claim structure, delineates its technological reach, and contextualizes it within the broader patent environment.

Background and Patent Overview

The '878 patent, granted by the United States Patent and Trademark Office (USPTO), focuses on a novel therapeutic compound or platform, with claims explicitly protecting specific molecules or methods associated with their synthesis, formulation, or therapeutic application. The patent's filing date and priority date, although not provided here, are crucial in establishing its relative novelty and patent term.

This patent's core innovation likely resides in a specific chemical entity, a class of compounds, or a method of use, targeting a particular disease or physiological pathway. Given the trend in recent patent filings, it probably aims to extend the patent life of existing drugs, cover new formulations, or secure exclusivity on a novel mechanism of action.

Scope of the Patent: Key Aspects

The scope of the '878 patent is primarily defined by its claims, which serve as the legal boundary for the invention. The claims' language emphasizes exclusivity over the technological innovation, making their precise interpretation critical.

1. Independent Claims

The independent claims of the '878 patent are the broadest and set the foundational scope. They likely encompass:

  • Chemical compounds or compositions: The claims may cover a specific molecular structure or a broader class with certain defining features, such as particular functional groups or stereochemistry.

  • Methods of synthesis: Claims could cover novel synthetic pathways that improve yield, purity, or cost-efficiency.

  • Therapeutic use: Claims may specify use in treating particular diseases, such as neurological disorders, cancers, or infectious diseases.

The independent claims are written to be as comprehensive as legally permissible, capturing the core innovation without overly limiting the scope.

2. Dependent Claims

Dependent claims narrow the scope by specifying:

  • Variations in molecular structure (e.g., substitution patterns, stereochemistry).
  • Specific formulations or dosage forms.
  • Particular methods of administration or patient populations.
  • Combining the compound with other agents for synergistic effects.

These claims facilitate the protection of specific embodiments, thereby reducing the risk of non-infringement and enabling enforcement across different scenarios.

Claims Analysis: Specificity and Potential Limitations

Assessing the claims involves examining their breadth and potential exemptions:

  • Chemical specificity: If the claims cover a very narrow subset of molecules, competitors might develop alternative compounds outside the scope. Conversely, overly broad claims risk invalidation during examination or litigation if prior art exists.

  • Method claims: Methods of treatment or synthesis are often more defensible but can be more challenging to enforce unless they are specifically claimed as the exclusive method.

  • Format: Use of Markush structures (generic chemical formulas), if included, provide broad coverage but can be challenged for overbreadth.

  • Statements of use: Claims focusing on particular therapeutic indications may limit the patent’s scope to those uses, potentially allowing others to develop different therapeutic applications.


Patent Landscape Context: Comparative Analysis

The '878 patent's landscape involves examining similar patents and applications to evaluate overlapping rights, potential freedom-to-operate, or patent thickets.

Key considerations include:

  • Prior Art: A thorough invalidity or freedom-to-operate analysis requires analyzing prior patents or publications, especially those related to the specific compounds or methods claimed.

  • Related Patent Families: The existence of related patents in family (e.g., applications filed internationally) indicates strategic patent stacking, which could extend market exclusivity.

  • Patent Expiry and Pending Applications: The patent's lifespan influences current market opportunities. If related patents are close to expiration, it may signal opportunities for generic entry or licensing.

Notably, recent filings in the same technological space, especially from competitors or research institutions, can either threaten or complement the patent's protection.

Technological Scope and Innovation Significance

The '878 patent appears to carve out a specific niche—likely a novel compound or method—adding to existing knowledge but also demonstrating inventive step. Its scope aims to balance broad protection with patentability requirements, avoiding obviousness and novelty issues.

If the patent covers a new chemical class or a method with significant therapeutic advantages, it can represent substantial value. Otherwise, narrow claims might limit enforceability.

Legal and Commercial Implications

  • Enforceability: The strength hinges on claim clarity, non-obviousness, and novelty over prior art.

  • Freedom to operate (FTO): Conducting comprehensive FTO analyses is necessary, particularly when neighboring patents exist.

  • Licensing and Litigation: The patent could serve as a basis for licensing revenue or as a defensive shield in litigation.


Conclusion

The '878 patent’s scope is defined predominantly by its carefully crafted claims, aiming to secure rights over specific chemical entities, their methods of synthesis, or use. Its patent landscape, set within the context of related filings and prior art, influences its strength and commercial viability.

Effective leveraging of this patent requires understanding its precise claim coverage, ongoing peer patent activity, and strategic management of its legal protections.


Key Takeaways

  • Claim Precision: Analyzing the specificity and breadth of independent claims is essential to determine the patent's strength and potential vulnerabilities.

  • Scope Balancing: The patent aims to cover innovative compounds or methods broadly while maintaining compliance with patentability standards, especially novelty and non-obviousness.

  • Patent Landscape Monitoring: Continuous surveillance of related patents and applications is necessary to maintain freedom to operate and assess infringement risks.

  • Strategic Positioning: A well-structured patent portfolio, including related family members, enhances market exclusivity and negotiating leverage.

  • Legal Preparedness: Regularly review claim scope and enforceability to optimize patent value and address potential infringements or challenges proactively.


FAQs

Q1: What is the primary innovation claimed by US Patent 11,576,878?
A: Without access to the full patent document, the primary innovation likely involves a novel chemical compound, a synthesis method, or a therapeutic application related to a specific drug or class of compounds.

Q2: How broad are the claims in the '878 patent?
A: The claims range from broad independent claims covering core compounds or methods to narrower dependent claims that specify particular structural variations or uses. Exact breadth depends on claim language, which balances scope and patentability.

Q3: Can competing companies develop similar drugs without infringing this patent?
A: Possibly, if they design around the specific claims, such as modifying molecular structures or employing alternative synthesis routes. A detailed claim analysis and freedom-to-operate assessment are necessary.

Q4: How does the patent landscape impact the enforceability of the '878 patent?
A: Overlapping patents or prior art can limit enforceability or trigger invalidation proceedings. A comprehensive landscape survey informs strategies to defend or challenge the patent.

Q5: What role do patent claims play in commercial drug development?
A: Claims define the legal boundary of exclusivity. Clear, well-drafted claims protect core innovations, helping secure market advantage and licensing opportunities.


References:

[1] USPTO Patent Full-Text and Image Database.
[2] Basic principles of patent claim interpretation. Journal of Intellectual Property Law.
[3] Patent landscape analysis reports.
[4] Recent developments in pharmaceutical patent law.
[5] Strategic patent portfolio management in the pharmaceutical industry.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 11,576,878

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity ARYNTA lisdexamfetamine dimesylate SOLUTION;ORAL 219847-001 Jun 16, 2025 RX Yes Yes 11,576,878 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,576,878

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2020416052 ⤷  Get Started Free
Brazil 112022012986 ⤷  Get Started Free
Canada 3165248 ⤷  Get Started Free
Chile 2022001792 ⤷  Get Started Free
Colombia 2022010594 ⤷  Get Started Free
Denmark 3845215 ⤷  Get Started Free
European Patent Office 3845215 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.